Common Contracts
9 similar License Option Agreement contracts by Allergan Specialty Therapeutics Inc, Allergan Inc, Alza Corp, others
Executed Document Control Number 99-32-00729 Ex-10.5 LICENSE OPTION AGREEMENTLicense Option Agreement • December 8th, 1999 • Manhattan Scientifics Inc • California
EXHIBIT 10.3.47 LICENSE & OPTION AGREEMENT THIS AGREEMENT entered into this 1st day of April, 1998, between Neoprobe Corporation, a Delaware corporation with principal offices at 425 Metro Place North, Suite 300, Dublin, Ohio 43017-1367 (hereinafter...License & Option Agreement • August 14th, 1998 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Ohio
BACKGROUNDLicense Option Agreement • May 14th, 1998 • Allergan Specialty Therapeutics Inc • Pharmaceutical preparations • California
BACKGROUNDLicense Option Agreement • March 13th, 1998 • Allergan Inc • Pharmaceutical preparations • California
BACKGROUNDLicense Option Agreement • December 15th, 1997 • Allergan Specialty Therapeutics Inc • Pharmaceutical preparations • California
This License Option Agreement (the "Agreement") is made as of the 5th day of September, 1997 by and between ALZA Corporation, a Delaware corporation ("ALZA"), and Crescendo Pharmaceuticals Corporation, a Delaware corporation ("Crescendo"). BACKGROUND...License Option Agreement • November 6th, 1997 • Alza Corp • Pharmaceutical preparations • California
BACKGROUND ----------License Option Agreement • July 15th, 1997 • Crescendo Pharmaceuticals Corp • California
LICENSE OPTION AGREEMENT ------------------------ THIS AGREEMENT, effective the 18th day of December, 1996, is made and entered by and between Palatin Technologies, Inc., a New Jersey corporation, with office 214 Carnegie Center, TES 100, Princeton,...License Option Agreement • April 30th, 1997 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • New York
RECITALSLicense Option Agreement • March 31st, 1997 • Therapeutic Discovery Corp • Pharmaceutical preparations • California
